Hepatitis B surface antigen (HBsAg) prevalence (%) in Guinea
Guinea: Hepatitis B surface antigen (HBsAg) prevalence was 2.8% in 2024. ▲ Rising
Latest (2024)
2.8%
Change on year
up 3.7%
World rank
7th
of 194 countries
All-time high
3.2%
in 2019
All-time low
2.2%
in 2015
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Guinea, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Guinea is 2.8%, measured in 2024.
That represents a change of up 3.7% on the previous year and up 27.3% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Guinea peaked at 3.2% in 2019 and was at its lowest, 2.2%, in 2015.
That places Guinea 7th out of 194 countries with data for 2024, putting it in the top 10%.
Hepatitis B surface antigen (HBsAg) prevalence in Guinea, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 2.2% | — |
| 2016 | 2.5% | +13.6% |
| 2017 | 2.7% | +8.0% |
| 2018 | 3.1% | +14.8% |
| 2019 | 3.2% | +3.2% |
| 2020 | 2.8% | -12.5% |
| 2021 | 2.6% | -7.1% |
| 2022 | 2.7% | +3.8% |
| 2023 | 2.7% | +0.0% |
| 2024 | 2.8% | +3.7% |
Guinea compared with similar countries
- Guinea's 2.8% is above the median for lower middle income countries, which is 0.6%, 4.7× the median. (47 countries reporting)
- Guinea's 2.8% is above the median for Sub-Saharan Africa, which is 1.1%, 2.7× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2.7% | 2.2% | 3.2% | 5 |
| 2020s | 2.7% | 2.6% | 2.8% | 5 |
Countries ranked near Guinea
- 5 Angola 3.1% compare
- 6 Syria 2.9% compare
- 8 Guinea-Bissau 2.7% compare
- 8 Nigeria 2.7% compare
- 10 Papua New Guinea 2.5% compare
More health data for Guinea
- Un projection of annual infant deaths, annual growth rate -1.65 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8529 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,123 deaths per 1,000 people (2090)
- Number of infants who die before age 1 11,190 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 113 (2025)
- Population ages 00-04, female, annual growth rate 0.9852 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0731 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.9785 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Guinea?
- Hepatitis b surface antigen (hbsag) prevalence in Guinea was 2.8% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Guinea?
- The highest recorded value was 3.2% in 2019.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Guinea?
- The lowest recorded value was 2.2% in 2015.
- How does Guinea rank for hepatitis b surface antigen (hbsag) prevalence?
- Guinea ranks 7th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Guinea?
- Over the last ten years it is up 27.3%. The long-run trend across the full record is rising.
- Where does this Guinea data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).